risk | cpnp.org

Home
About CPNP
- Why Join CPNP
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Awards
- CPNP Foundation
- Corporate Sponsorships
  - Sponsor Program
  - Sponsors
- Information for Patients
- Contact CPNP
Education
- April 2013 Annual Meeting in Colorado Springs, CO
- April 2014 Annual Meeting in Phoenix, AZ
- CPNP University Online Courses
- Drug-Induced Movement Disorders Training DVD
- Psychiatric Pharmacotherapy for Nurses
- Other Meetings
- Find More Resources in My CPNP
  - My CPNP Presentations & Exams
  - My CPNP ACPE Transcript Center
BCPP
- BCPP Exam Preparation
  - BCPP Exam Preparation
  - Certification FAQ
- BCPP Recertification
Careers/Residencies
Member Center
- Member Toolkit
- Email List
- Member Directory
- CPNP Documents and Reports
- Member Hubs
  - Pharmacy Student Hub
  - New Practitioner Hub
Resources
Gov't and Prof Affairs
- Comprehensive Medication Management
- Government Affairs
  - Contacting Legislators and Policy Makers
  - Medicare Coverage Initiative with ACCP
- Position/White Papers
  - Psychiatric Pharmacy Manifesto
  - Psychiatric Pharmacist Integration into the Medical Home Model
My CPNP
- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities

risk

Effects of a brief Early Start Denver model (ESDM)-based parent intervention on toddlers at risk for autism spectrum disorders: a randomized controlled trial.

Rogers SJ, Estes A, Lord C, et al. Effects of a brief Early Start Denver model (ESDM)-based parent intervention on toddlers at risk for autism spectrum disorders: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2012;51(10):1052-65. doi:10.1016/j.jaac.2012.08.003.

Aspirin for primary prevention of cardiovascular disease events.

Nemerovski CW, Salinitri FD, Morbitzer KA, Moser LR. Aspirin for primary prevention of cardiovascular disease events. Pharmacotherapy. 2012;32(11):1020-35. doi:10.1002/phar.1127.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013;368(8):709-18. doi:10.1056/NEJMoa1113697.

Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program.

Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309(4):342-3. doi:10.1001/jama.2012.94856.

Enhanced tracking of tissue for transplantation.

DePaolo JS, Barbeau JM. Enhanced tracking of tissue for transplantation. JAMA. 2013;309(5):443-4. doi:10.1001/jama.2012.145043.

Improving population health in US cities.

Stine NW, Chokshi DA, Gourevitch MN. Improving population health in US cities. JAMA. 2013;309(5):449-50. doi:10.1001/jama.2012.154302.

A piece of my mind. Falling off the edge.

Inouye SK, O'Connell JJ, Puelle MR. A piece of my mind. Falling off the edge. JAMA. 2013;309(5):451-2. doi:10.1001/jama.2012.214089.

Opioid analgesics for rheumatoid arthritis pain.

Whittle SL, Richards BL, Buchbinder R. Opioid analgesics for rheumatoid arthritis pain. JAMA. 2013;309(5):485-6. doi:10.1001/jama.2012.193412.

Community research partnerships: underappreciated challenges, unrealized opportunities.

Kulynych J, Heffernan KG. Community research partnerships: underappreciated challenges, unrealized opportunities. JAMA. 2013;309(6):555-6. doi:10.1001/jama.2012.108937.

Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children.

Surén Pål, Roth C, Bresnahan M, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013;309(6):570-7. doi:10.1001/jama.2012.155925.